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Background: Actinobacillus pleuropneumoniae is a Gram-negative bacterium and a member of the Pasteurellaceae
family. This bacterium is the causative agent of porcine pleuropneumonia, which is a highly contagious respiratory
disease causing important economical losses to the worldwide pig industry. It has been shown that A.
pleuropneumoniae can form biofilms on abiotic surfaces (plastic and glass). Although in vitro models are extremely
useful to gain information on biofilm formation, these models may not be representative of the conditions found at
the mucosal surface of the host, which is the natural niche of A. pleuropneumoniae.
Results: In this paper, we describe a method to grow A. pleuropneumoniae biofilms on the SJPL cell line, which
represents a biotic surface. A non-hemolytic, non-cytotoxic mutant of A. pleuropneumoniae was used in our assays
and this allowed the SJPL cell monolayers to be exposed to A. pleuropneumoniae for longer periods. This resulted in
the formation of biofilms on the cell monolayer after incubations of 24 and 48 h. The biofilms can be stained with
fluorescent probes, such as a lectin against the polymer of N-acetyl-D-glucosamine present in the biofilm matrix,
and easily observed by confocal laser scanning microscopy.
Conclusions: This is the first protocol that describes the formation of an A. pleuropneumoniae biofilm on a biotic
surface. The advantage of this protocol is that it can be used to study biofilm formation in a context of host-pathogen
interactions. The protocol could also be adapted to evaluate biofilm inhibitors or the efficacy of antibiotics in the
presence of biofilms.
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Host-pathogen interactionBackground
Actinobacillus pleuropneumoniae, a Gram-negative bac-
terium belonging to the Pasteurellaceae family, is the
causative agent of porcine pleuropneumonia. This severe
and highly contagious infectious respiratory disease causes
major economic losses in the swine industry [1,2]. A.
pleuropneumoniae is transmitted by means of aerosols or
by direct contact with infected animals. The infection may
result in rapid death or in severe pathology [1]. Animals
exposed to A. pleuropneumoniaemay develop chronic infec-
tions or become asymptomatic carriers and these animals
may become the source of transmission of the disease to
healthy animals or herds [1]. The virulence factors involved* Correspondence: mario.jacques@umontreal.ca
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reproduction in any medium, provided the orin colonization and lung lesions, which include type IV fim-
briae, lipopolysaccharides, and the pore forming RTX toxins
ApxI to IV, have been well characterized (for a recent review
see [2]). The role of biofilm formation in the pathogenicity
of A. pleuropneumoniae is gaining recognition.
Bacterial biofilms are structured clusters of bacterial cells
enclosed in a self-produced polymer matrix that are at-
tached to a surface [3-5]. Bacteria can adhere to a biotic sur-
face (e.g. cells at the mucous layer) as well as to abiotic
surfaces (e.g. floor or equipment found at a farm). The poly-
mer matrix is often composed of exopolysaccharides, pro-
teins and nucleic acids. The biofilm protects bacteria from
hostile environmental conditions. Bacteria within a biofilm
can resist attack from the host immune response, and are
less sensitive than planktonic cells to desiccation and to the
action of biocides.
It has been clearly shown that A. pleuropneumoniae
has the ability to form biofilms under static growthal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tation in glass tubes [6,8]. Using a 96-well microtiter plate
assay, we screened mutants obtained by transposon muta-
genesis for their biofilm phenotype and identified unique
genetic determinants associated with biofilm formation in A.
pleuropneumoniae [8]. We also demonstrated that the
biofilms of A. pleuropneumoniae field isolates were more re-
sistant than their planktonic counterpart to ampicillin,
florfenicol, tiamulin and tilmicosin [9]. Recently, our group
demonstrated that A. pleuropneumoniae can form a biofilm
on a glass slide under low-shear force in a drip-flow appar-
atus [10]. The biofilm formation on abiotic surfaces (plastic
and glass) depends on the production of a polymer of β-1,6-
N-acetyl-D-glucosamine (PGA) [10-12]. Although in vitro
models used in biofilm studies are extremely valuable to ac-
quire knowledge regarding biofilm formation, the main limit
of these in vitro models is that they do not mimic exactly
the conditions found in the host such as the lung mucosa,
which is a natural niche for A. pleuropneumoniae. There-
fore, the aim of this study was to develop a method to form
biofilms on a biotic surface. We selected the SJPL cell line
because this cell line has been used extensively in our la-
boratory to study adherence of A. pleuropneumoniae and
other porcine bacterial pathogens to cells [13]. In addition,
this cell line was found to be permissive to porcine repro-
ductive and respiratory syndrome virus (PRRSV) infection
[14] and therefore represents a potential and powerful
model to study viral-bacterial co-infections.
Results and discussion
A non-hemolytic strain of A. pleuropneumoniae with dele-
tions in the apxIC and apxIIC genes, named MBHPP147,
was used in this study. We first determined the ability of this
strain to form a biofilm using a standard microtiter plate
assay combined with crystal violet staining (Figure 1). Strain
MBHPP147 was able to form biofilms on the plastic surface
and, as previously observed with the A. pleuropneumoniaeFigure 1 Effect of incubation time on the biofilm dispersion of A. pleu
microtiter plates.S4074 parent strain [7], a robust biofilm was formed within
4 hours but rapidly dispersed afterwards. Such rapid disper-
sion has been observed previously with strain S4074 but the
exact cause has yet to be identified [10]. The presence of the
biofilm was confirmed by confocal laser scanning micros-
copy by staining the biofilm matrix with Wheat Germ Ag-
glutinin (WGA)-Oregon green 488 (Figure 2). This lectin is
known to bind to the PGA present in the biofilm matrix of
A. pleuropneumoniae [11,12].
We then verified that strain MBHPP147 was also non-
cytotoxic for the SJPL cells. Cytotoxicity was measured
using the level of activity of lactate dehydrogenase (LDH)
released from cells. Cells were incubated for up to 96 hours
without or with bacteria and no statistically significant dif-
ferences were observed between the % cytotoxicity of the
uninfected controls and the SJPL cells incubated with
strain MBHPP147 (Table 1). For strain S4074, cytotoxicity
reaches over 50% after 3 hr of incubation with SJPL cells
(data not shown). Therefore strain MBHPP147 is a suit-
able A. pleuropneumoniae mutant for protocols, such as
biofilm formation, requiring long incubation periods with
animal cells.
The next step was to evaluate the ability of strain A.
pleuropneumoniae MBHPP147 to form biofilm on a bi-
otic surface (i.e. on a SJPL cell monolayer). Therefore, A.
pleuropneumoniae MBHPP147 was incubated with SJPL
cells for up to 48 hours. Confocal laser scanning micros-
copy and staining with WGA-Oregon green 488 was
used to visualize the biofilms (Figure 3). Uninfected SJPL
cells were used as a negative control, and, as expected,
were devoid of any adherent bacteria (Figure 3A). The
cells were stained with WGA because this lectin binds
to N-acetyl-glucosamine and N-acetyl-neuraminic resi-
dues. There was no obvious biofilm formation after 3 h
(Figure 3B) and 6 h (Figure 3C) of incubation despite
the attachment of A. pleuropneumoniae MBHPP147 on
SJPL cells (Figure 4). A. pleuropneumoniae MBHPP147ropneumiae strain S4074 and MBHPP147 in 96-well polystyrene
Figure 2 Confocal laser scanning microscopy images of 6-hour biofilms of A. pleuropneumoniae strain MBHPP147 stained with
WGA-Oregon green 488. Biofilms were formed in 6-well and 96-well polystyrene plates.
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after 24 hours (Figure 3D) and 48 hours (Figure 3E) of in-
cubation. The formation of biofilms was associated with an
increased in the number of bacteria attached to SJPL cells
(Figure 4). The 24 h and 48 h biofilms were stained with
WGA suggesting the presence of PGA in the matrix as ob-
served previously with abiotic surfaces [7,10-12]. The pres-
ence of PGA was confirmed by the dispersion of the
biofilm (Figure 3F), and the decrease in the number of bac-
teria attached to SJPL cells (Figure 4) when the biofilms
were treated with Dispersin B, a glycoside hydrolase that
catalyzes the hydrolysis of poly-N-acetylglucosamine. To
further ensure that the WGA staining observed was associ-
ated with the biofilm of A. pleuropneumoniae MBHPP147,
the assay was repeated with a bacterial strain expressing a
plasmid encoded GFP from a constitutive promoter [15]. A
GFP signal was detected for SJPL cells infected with A.
pleuropneumoniae and it was not detected when cells were
not infected (Figure 5). This indicated that bacteria were
attached to the cells. Furthermore, the GFP patternTable 1 Cytotoxicity as measured by lactate
dehydrogenase (LDH) released by SJPL cells incubated
with A. pleuropneumoniae strain MBHPP147 for a period




Control SJPL cells SJPL cells infected with
A. pleuropneumoniae
24 0 0
48 4.93 ± 4.93 14.67 ± 7.55
72 10.60 ± 10.60 8.15 ± 8.15
96 21.05 ± 21.05 22.65 ± 20.65
*The % represents the released LDH/ total cellular LDH and the data are the
means ± SEM of three independent experiments with duplicates. No statistical
differences were observed between the control cells and the cells infected
with A. pleuropneumoniae strain MBHPP147 (two-way ANOVA).exhibited by the bacteria on SJPL cells was very similar to
the one observed with WGA staining (Figure 5). Addition-
ally, the WGA staining observed in the uninfected cells
appeared to follow the pattern of the phalloidin staining of
the cytoskeleton (Figure 5). Taken together, this indi-
cated that the observed change in WGA-staining pat-
tern (Figures 3 and 5) is clearly due to the formation of
biofilm by A. pleuropneumoniae and not due to a struc-
tural change on the surface of SJPL cells.
Unlike biofilms formed on an abiotic surface [10], the
biofilms formed on SJPL cells was present after 24 and
48 hours. Furthermore, A. pleuropneumoniae S4074 and
MBHPP147 were not able to form biofilms in the culture
medium used to grow SJPL cells in the absence of SJPL
cells (data not shown). Taken together, these observations
underline the importance of bacterium-animal cell interac-
tions in biofilm formation and the use of a biotic surface.
This conclusion is also supported by the fact that exposing
Streptococcus pneumoniae to the airway epithelial cells
1HAEo-before a biofilm assay resulted in a significant in-
crease in biofilm formation in microtiter plates [16].
Only a few co-culture models have been described in the
literature to study human respiratory tract pathogens. For
example, S. pneumoniae can form biofilms on NCI-H292
(mucoepidermoid bronchial carcinoma cells) and primary
human bronchial epithelial cells [17]. While the majority of
primary bronchial epithelial cells remained intact after
24 hours of incubation with S. pneumoniae, the NCI-H292
cells were rapidly killed by the bacteria. Recently, Vidal
et al. [18] developed a biofilm reactor with living cultures of
human-derived lung cells A549 and a continuous flow of
nutrients to avoid the cytotoxic effect of S. pneumoniae.
Another example is Pseudomonas aeruginosa that can form
biofilms on cystic fibrosis-derived human airway epithelial
cells [19]. However, the biofilm disrupted the monolayer
after an overnight incubation in the absence of antibiotics.
Figure 3 Confocal laser scanning microscopy images of biofilms of A. pleuropneumoniae strain MBHPP147 grown on SJPL cells and
stained with WGA-Oregon green 488. Uninfected SJPL cell control (48 hours post mock infection) (A); SJPL cells incubated with A.
pleuropneumoniae strain MBHPP147 for 3 hours (B), 6 hours (C), 24 hours (D), 48 hours (E) or 48 hours and treated with Dispersin B (F).
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film formation by A. pleuropneumoniae on a biotic surface
and for long incubation periods. In previous works [13],
we have determined the SJPL cells’protein profile after a
short incubation of 3 hours with A. pleuropneumoniae asFigure 4 Number of colony forming units (CFU) attached to
SJPL cells. SJPL cells were infected with A. pleuropneumoniae
strain MBHPP147 and attached cells were recovered after 3, 6,
24, and 48 hours of incubation and after a Dispersin B
treatment (48 h + Dispersin B).well as the transcriptomic profile of A. pleuropneumoniae
during that interaction. It will be interesting in future stud-
ies to use this new protocol to investigate the SJPL cell’s re-
sponse to bacterial biofilms present after 24 and 48 hours
of co-culture. It will also be interesting to compare A.
pleuropneumoniae gene expression in a mature biofilm
formed on a biotic surface with the genes expression deter-
mined with mature biofilms on plastic (polystyrene micro-
titer plate) or glass (drip-flow apparatus) surfaces [10].
Additionally, the protocol could be adapted and design to
screen for anti-adherence and/or anti-biofilm molecules.
Conclusions
The use of a non-hemolytic, non-cytotoxic strain of A.
pleuropneumoniae allows for longer incubation periods
with an in vitro cell line model. Others have used
paraformaldehyde-fixed epithelial cells to avoid the cyto-
toxic effect of a bacterial pathogen [17]. Although cell
monolayers do not perfectly reproduce the in vivo condi-
tions, the use of a biotic surface is certainly more physiolo-
gically relevant to study biofilm formation than a plastic or
a glass surface. This model could be easily adapted to
evaluate inhibitors of bacterial adherence or inhibitors of
biofilm formation, or the efficacy of antibiotics in the pres-
ence of a biofilm. Finally, this model can also be adapted to
study bacterial-viral co-infections knowing that the SJPL
cells are permissive to PRRSV [14].
Methods
Bacterial strain
A. pleuropneumoniae MBHPP147 is a non-hemolytic
derivative of the serotype 1 reference strain S4074.
Figure 5 Confocal laser scanning microscopy images of a 24 hour biofilm of A. pleuropneumoniae strain MBHPP147 expressing GFP
grown on SJPL cells and stained with Phalloidin-AlexaFluor 594 and WGA-AlexaFluor 633.
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EP 0810283A2. Briefly, a streptomycin and nalixidic acid
resistant mutant of A. pleuropneumoniae strain 4074
(MBHPP104) was mated with an Escherichia coli SM10
λpir strain carrying a plasmid containing a deleted apxIC
gene. Positive exconjugants were selected on solid me-
dium containing nalixidic acid and gentamycin and a
mutant with reduced haemolytic activity on solid CBM
containing 2% sheep erythrocyte was selected and named
MBHPP111. Once the deletion was confirmed, this mu-
tant was then mated with an E. coli S17-1 λpir strain car-
rying a plasmid containing an in-frame deletion in the
apxIIC gene. Exconjugants were selected on solid media
supplemented with nalixidic acid and gentamycin. A mu-
tant lacking hemolytic activity on blood agar was se-
lected and was named MBHPP147. In summary, strain
MBHPP147 contains deletions in both the apxIC and
apxIIC genes. The protoxins ApxIA and ApxIIA are
formed and exported but are not acylated, and thus not
activated, due to the absence of the ApxC proteins. The
bacterial strain was cultured on brain heart infusion
(BHI) broth (Oxoid Ltd, Basingstoke, Hampshire, England)
or on BHI agar supplemented with 5 or 15 μg/mL nicotina-
mide adenine dinucleotide (NAD) (BHI-NAD), respectively,
at 37°C in 5% CO2. A. pleuropneumoniae MBHPP147 was
transformed by electroporation with pMC-Express, a plas-
mid for GFP expression [15], as described before [20].
Transformants were selected on BHI agar with chloram-
phenicol (1 μg/ml).
Cell culture
The St. Jude porcine lung epithelial cell line (SJPL) (St.
Jude Children’s Hospital, Memphis, TN, USA) [21,22] wasgrown in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco, Burlington, ON, Canada) supplemented with 10%
of fetal bovine serum (Gibco), 1% sodium pyruvate (100×,
Gibco), 1% L-glutamine (200 mM, Gibco), 1,5% MEM
nonessential amino acids (100×, Gibco), 1% penicillin/
streptomycin (100×, Gibco), 1% fungizon (250 μg/ml,
Gibco) and 0,1% gentamicin [21]. Cells were grown at 37°C
in 5% CO2. Despite its name, the SJPL cell line was recently
shown to be from monkey origin [22].
Cytotoxicity detection assay
For the cytotoxicity detection assay, 105 epithelial cells in
complete DMEM without antibiotics were seeded into
wells of 24-well tissue culture plates (Sarstedt, Numbrecht,
Germany) and incubated O/N. Cells were infected with A.
pleuropneumoniae strain MBHPP147. Bacteria from an
overnight culture grown at an OD600nm of 0.6 were diluted
in complete DMEM cell culture medium without antibi-
otics and supplemented with NAD (5 μg/mL) to a concen-
tration of 106 CFU/ml. One ml of this suspension was
added to each well at a multiplicity of infection (MOI) of
10:1, and the plates were incubated for up to 96 hours.
The cellular cytotoxicity was determined using the lactate
dehydrogenase (LDH)-measuring CytoTox 96 nonradio-
active cytotoxicity assay (Promega, Madison, WI) as pre-
scribed by the manufacturer. Non-infected cells were
used as a negative control, while total lysis of cells by a
treatment with the lysis solution represented the
100%-cytotoxicity positive control. Optical densities
were measured at 490 nm with a microplate reader and
percentage of cytotoxicity was calculated using the fol-
lowing formula: (OD490 treated well/OD490 positive
lysis control well) × 100.
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A static microtiter plate biofilm assay was used as de-
scribed by Tremblay et al. [10]. The wells of a sterile 96-
well polystyrene microtiter plate (Costar® 3599, Corning,
NY, USA) were filled in triplicate with a dilution (1/100)
of an overnight bacterial culture. Following an incuba-
tion of 4 to 24 h at 37°C, the medium was removed by
aspiration and the wells were then washed by immersion
in water. The water was then removed by aspiration and
the excess water was removed by inverting plates onto a
paper towel. The wells were then filled with 100 μL of
crystal violet (0.1%) and the plate was incubated for
2 min at room temperature. After removal of the crystal
violet solution, the plate was washed and dried in 37°C
for 30 min and 100 μL of ethanol (70%) were added to
the wells. Absorbance was measured at 590 nm using a
spectrophotometer (Powerwave, BioTek Instruments,
Winooski, VT, USA).
Biofilm assay with a biotic surface
Bacteria (500 μl) from an overnight culture were trans-
ferred in 5 ml of fresh BHI-NAD and were grown at 37°C
with agitation (200 rpm) until an OD600nm of 0.6. Bacteria
were then diluted to a concentration of 2.5 × 106 CFU/ml
in complete DMEM cell culture medium without antibi-
otics and supplemented with NAD. The medium was re-
moved from wells of 96 well-microtiter plates containing
confluent monolayers of SJPL cells and 100 μL of the bac-
terial dilution in DMEM-NAD were added (MOI of 10:1).
Plates were incubated at 37°C in 5% CO2 for 3, 6, 24, or
48 hr. To disperse the biofilms, 100 μL of a Dispersin B so-
lution (0.4 μg/mL in Dubelcco’s phosphate-buffered saline
[DPBS]; Kane Biotech Inc., Winnipeg, MB, Canada) was
added to the well and the plate was incubated for 5 min at
37°C. After the desired incubation period, culture medium
was removed and the wells washed 3× with PBS.
Quantification of A. pleuropneumoniae attached to
SJPL cells
Adherent bacteria were quantified as described previously
[13]. Briefly, SJPL cells were seeded into 24-well tissue cul-
ture plates as described in the cytotoxicity assay. Bacteria
were prepared as described above and 1 ml of the bacterial
suspension was added to each well. The plates were incu-
bated for 3, 6, 24 and 48 hours. When necessary, bacteria
in biofilms were dispersed by adding 100 μL of a Dispersin
B solution (4 μg/mL in DPBS) to the well and the plate
was incubated for 5 min at 37°C. Nonadherent bacteria
were removed by washing four times with DPBS. Cell with
adherent bacteria were released from the wells by adding
100 μl of 1× trypsin-EDTA (Gibco) and resuspended in
900 μl DPBS buffer. The recovered suspension was serially
diluted and these were plated on agar to determine the
number of adherent bacteria.Confocal laser scanning microscopy
Biofilms were grown on a biotic or an abiotic surface as de-
scribed above. SJPL cells were fixed in formaldehyde (4%)
for 1 hr at room temperature and wells were washed 3 more
times with PBS. The wells were filled with 100 μl of WGA–
Oregon green 488 or WGA-AlexaFluor 633 (Invitrogen,
Eugene, OR, USA) diluted 1/100 in PBS or/and Phalloidin-
AlexaFluor 594 (Invitrogen) diluted 1/40 in PBS and the
plate was incubated for 30 min at room temperature in
the dark. The plate was then washed with water and filled
with 100 μl PBS. The plate was observed with a confocal
microscope (Olympus FV1000 IX81, Markham, ON,
Canada). The fluorophores were excited and detected
as prescribed by the manufacturers. The images were
acquired using the Fluoview software (Olympus).
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